Results 71 to 80 of about 29,158 (227)
Risk Management and Insurance Review, EarlyView.Abstract This study examines whether underwriting methods—representation, medical examination, extra premiums, and coverage—effectively mitigate adverse selection using data from an insurance company. Regarding representation, we focus on statements disclosing pre‐existing medical conditions.
Chia‐Ling Ho +3 more
wiley +1 more source
, 2009 Secondary hyperparathyroidism is sometimes seen in patients with hypophosphatemic osteomalacia after long-term oral phosphate therapy. Parathyroidectomy is sometimes needed for the correction of hypercalcemia in these patients, and is rarely performed in
蘇登煌;廖國盟;張英俊;蔡克嵩 +1 more
core
Veterinary Clinical Pathology, EarlyView.Abstract Urinary extracellular vesicles (UEVs) are membranous particles that carry renal tubular transporter proteins. Here, we evaluate whether selected renal tubular transporter proteins can be detected in UEVs isolated from small volume (1–5 mL) canine urine samples of healthy dogs and canine patients with elevated circulating parathyroid hormone ...
L. J. McGravey +2 more
wiley +1 more source
Eurasian Journal of Medicine, 2019 Parathyroid hormone (PTH) has been shown to enhance erythrocyte osmotic fragility and has been incriminated as a factor in the anemia seen in patients with chronic renal failure and secondary hyperparathyroidism.
Celalettin Koşan, Lale Sever
doaj
International Journal of Endocrinology, 2009 Brown tumour represents a serious complication of hyperparathyroidism. Differential diagnosis, based on histological examination, is only presumptive and clinical, radiological and laboratory data are necessary for definitive diagnosis. Here we describe
Nicola Di Daniele +6 more
doaj +1 more source
Multiple brown tumors in a patient with nutritional secondary hyperparathyroidism.
, 1989 For years, brown tumors have been considered to be a characteristic of primary hyperparathyroidism. However, since 1963 several reports indicate that the incidence of brown tumors in patients with renal secondary hyperparathyroidism to be 1.5%-1.7%.
Mergenthaler, H.G. +4 more
core +1 more source
, 2020 CONTEXT Recent studies support a bidirectional interaction between aldosterone and parathyroid hormone (PTH), possibly increasing the individual cardiovascular risk.
Quinkler, Marcus +10 more
core +1 more source
Experimental Physiology, EarlyView.Abstract Chronic kidney disease–mineral and bone disorder (CKD‐MBD) is a major complication of chronic kidney disease (CKD), characterized by disruptions in mineral metabolism, abnormal bone turnover and vascular calcification, which collectively increase the risk of fractures and cardiovascular disease.
Alief Waitupu +4 more
wiley +1 more source
Mandibular Osteitis Fibrosa Cystica as First Sign of Vitamin D Deficiency
Case Reports in Dentistry, 2018 Introduction. Brown tumors of hyperparathyroidism are locally destructive bone lesions. They are the late clinical consequence of the disease. They can occur in primary, secondary, and rarely tertiary forms.
Nour Mellouli +5 more
doaj +1 more source
, 2017 Background: The imaging techniques most commonly used in the diagnosis of hyperparathyroidisms are ultrasound and scintigraphy. The diagnostic algorithms vary, depending mainly on the population, and experience of physicians.
Katarzyna Fronczewska-Wieniawska +15 more
core +1 more source